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http://dx.doi.org/10.1016/j.jmii.2013Background: The epidemiology of bacterial meningitis varies in different areas, age groups,
and times. To know the trend of neonatal and childhood bacterial meningitis in northern
Taiwan, we performed this 29-year-long assessment.
Methods: Eligible patients were aged 18 years or younger, hospitalized in Mackay Memorial
Hospital between 1984 and 2012, and proven by positive cerebrospinal fluid bacterial cultures.
Analysis included the patient numbers and pathogens in different age groups, periods, compli-
cations, and outcomes.
Results: Males were predominant in all the age groups through the years. Almost half of the
patients were in the neonatal period. Patient numbers went up in the early study period
and declined after 1993e1997. Group B Streptococcus and Escherichia coli were the most com-
mon pathogens in neonates, whereas in childhood were Streptococcus pneumoniae and Hae-
mophilus influenzae type b (Hib). Patient numbers of Group B Streptococcus,
S. pneumoniae, and Hib meningitis declined in the late study period, but E. coli meningitis
increased. The mortality rate decreased but sequela rate increased. Among the four most com-
mon pathogens, S. pneumoniae had the worst outcome and had highest mortality rate. All Hib
meningitis patients survived, but their sequela rate was the highest.
Conclusion: This study provides an epidemiological data on trends of neonatal and childhood
bacterial meningitis in northern Taiwan during the past 29 years, including male and neonatalof Pediatrics, Mackay Memorial Hospital, Number 92, Section 2, Zhongshan North Road, Taipei 10449,
org.tw (N.-C. Chiu).
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Bacterial meningitis 297predominance, decrease of total patient number in recent years, change of major pathogens,
and declined mortality but raised morbidity.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
The main pathogens of bacterial meningitis are known to be
different in different age groups, eras, and geographic
areas. Group B Streptococcus (GBS), Escherichia coli, and
Listeria monocytogenes are the most common causative
organisms of neonatal bacterial meningitis in western
countries,1,2 but L. monocytogenes is hardly found in
neonatal meningitis of Asian countries, including
Taiwan.3e6 Haemophilus influenzae type b (Hib), Strepto-
coccus pneumoniae, and Neisseria meningitidis are
considered to be the three most common pathogens for
childhood bacterial meningitis prior to introducing the
specific vaccines. However, the incidence of Hib meningitis
in Taiwan was found to be lower than that in western
countries in 1992e1994.7 Compared with some countries,
meningococcal meningitis is infrequently reported in
Taiwan. The annual incidence of meningococcal disease
was below 0.001/100,000 population between 1980 and
1987 and increased only to 0.2 cases/100,000 population in
2001.8 Vaccination frequently has great impact on specific
infectious diseases. In France, the invasive Hib disease in
children aged < 5 years declined by 96% 15 years after the
introduction of vaccination.9 In Senegal, a near elimination
of Hib meningitis burden was found after Hib conjugate
vaccine was implemented into their routine infant immu-
nization program.10 Pneumococcal conjugate vaccine also
has good results for decreasing disease burden.11,12 There
are some other factors that might influence the epidemi-
ology of bacterial meningitis. Because epidemiology
changes with time and place, knowing the local condition
would be very important for clinicians. Herein, we review
the data of proven bacterial meningitis in our pediatric
patients during the past 29 years to reveal the trends of
neonatal and childhood bacterial meningitis situations in
our area.
Materials and methods
Patient selection
The patients in this study were selected from the admin-
istrative database of the Mackay Memorial Hospital, a
medical center with around 200 pediatric beds in northern
Taiwan. The bed number had only minor changes during the
past three decades. This study was approved by the insti-
tutional review board of the hospital. The hospitalized
patients aged 18 years or younger with a positive cerebro-
spinal fluid (CSF) bacterial culture results during the period
from January 1984 to December 2012 were enrolled.
Tuberculous meningitis was excluded. Patients diagnosed as
having meningitis without bacteria isolated from the CSF
were not included, even those who had elevated CSF cellcounts, positive blood culture results, or clinical pre-
sentations of meningitis were excluded. The CSF cultures
yielded normal skin flora (e.g., coagulase-negative staph-
ylococci) considered to be contaminations were excluded
unless CSF cell counts and clinical presentations fit the
diagnosis of meningitis. Patients with evidence of congen-
ital infections were also excluded.
Data collection
We searched the patients from both the diagnostic data-
base and microbiological database to find eligible patients.
The analyzed data included patients’ age and sex, menin-
gitis occurrence year, CSF pathogens, complications, and
outcomes. If a patient had more than one spinal tap within
an episode of meningitis, only the first CSF result was
analyzed. If a patient had more than one episode of bac-
terial meningitis, i.e., recurrent meningitis, the findings
were calculated separately in each episode.
Statistical analysis
According to their age, the patients were divided into four
groups: <1 month; 1 month to <1 year, 1e6 years, and
7e18 years. We further divided the 29 years into 6 periods,
from 1984 to 1987, then every 5 years in each period. The
outcomes of the patients were classified into death, having
sequelae, recovery, and loss of follow-up. Sequelae were
defined as having consequent physical or psychological
morbidities lasting for >6 months after the meningitis
episode. Recovery was defined as survival without
sequelae.
We compared the patient numbers in different age
groups and periods, pathogens in different age groups and
periods, complications and outcomes in different age
groups, periods, and pathogens. The lost follow-up patients
were excluded from comparison of mortality rates. The
sequela rates and recovery rates were calculated only in
survivors.
Significant differences among different year periods,
age groups, and pathogens were determined by c2 or Fisher
exact test for comparison. Trends of patient numbers,
pathogens, and outcomes during the study period were
tested. All reported p < 0.05 were considered statistically
significant. Statistical analyses were performed using SPSS
version 20.0 software (SPSS, Inc., Chicago, IL, USA).
Results
Characteristics of patients
A total of 323 episodes of proven pediatric bacterial men-
ingitis were enrolled during the 29-year period. The male to
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Figure 1. Patient numbers in different year periods of 323
cases of pediatric bacterial meningitis.
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Figure 2. Patient numbers of the four most common path-
ogens of pediatric bacterial meningitis in different age groups.
298 M.-C. Lin et al.female ratio was 1.69. The male predominant trend was
found in all different age groups. Near half of the patients
were aged <1 month (148 patients, 45.8%); 107 patients
(33.1%) were aged 1 month to <1 year; 54 patients (16.7%)
were aged 1e6 years; and 14 patients (4.3%) were aged
7e18 years.
The patient numbers in different age groups during the
study period are shown in Fig. 1. The total patient numbers
had a mild decreasing trend in the past 10 years; i.e., >50
episodes occurred in each 4e5-year period prior to 2003
and dropped to near 40 episodes in the past two 5-year
periods. There was a significant decreased trend
(p Z 0.025) in patients aged <1 year, and an increased
trend (p Z 0.004) in patients >7 years. There was a surge
of patient number in 1995. Among the 28 episodes of thatTable 1 Pathogens of 323 cases of pediatric bacterial meningit
Pathogen <1 mo 1
Gram-positive bacteria 78 4
Group B streptococcus 55 1
Streptococcus pneumoniae 0 1
Group A streptococci 6
Enterococcus spp. 6
Streptococcus bovis 4
Other Gram-positive organismsa 7
Gram-negative bacteria 70 6
Escherichia coli 31 1
Haemophilus influenzae type b 0 1
Enterobacter cloacae 6
Klebsiella pneumoniae 6
Elizabethkingia meningosepticum 10
Neisseria meningitidis 1
Proteus mirabilis 6
Pseudomonas aeruginosa 2
Haemophilus parainfluenzae 2
Salmonella spp. 0
Alcaligenes spp. 0
Plesiomonas spp. 0
Other Gram-negative organismsb 6
a Other Gram-positive organisms included Listeria monocytogenes,
b Other Gram-negative organisms included Acinetobacter spp., Ent
oxytoca, and Moraxella spp.year, 16 occurred in neonates and 10 were GBS meningitis
but not from an outbreak.
Trends of pathogen change
GBS was the most common pathogen (70 episodes, 21.7%),
followed by S. pneumoniae (51 episodes, 15.8%), E. coli (47
episodes, 14.6%), Hib (23 episodes, 7.1%), group A strep-
tococci (15 episodes, 4.6%), Enterobacter cloacae (13 epi-
sodes, 4.0%), Klebsiella pneumoniae (12 episodes, 3.7%),
Elizabethkingia meningosepticum (12 episodes, 3.7%),
enterococci (10 episodes, 3.1%), and N. meningitidis (9
episodes, 2.8%). The common pathogens of different age
groups are shown in Table 1 and the four most common
pathogens in Fig. 2. GBS and E. coli were the most commonis in different age groups
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Figure 3. Year distribution of the four most common path-
ogens of pediatric bacterial meningitis.
Bacterial meningitis 299two pathogens of neonatal meningitis (37.2% and 20.9%);
they were also common pathogens up to age 1 year and
accounted for 27.1% and 18.4% in the patients of that age,
respectively. There was no S. pneumoniae or Hib meningitis
found below the age of 1 month, but they increased af-
terward. After age 1 year, S. pneumoniae and Hib became
the dominant pathogens (S. pneumonia, 35 episodes,
51.5%; Hib, 11 episodes, 16.2%), but no Hib meningitis pa-
tients aged > 6 years were found. There were nine patients
(2.8%), distributed in different age groups, got N. menin-
gitidis infection.
The year distribution of four predominant pathogens was
shown in Fig. 3. The patient number of GBS in 1995 was
extraordinarily high, but no significant change otherwise.
The number of E. coli patients remained stable during the
29 years and became larger than that of GBS in the past 5-
year period. The number of S. pneumoniae patients peaked
in 1994e1997 then decreased, and no patient was found in
2011 or 2012. Apart from a surge in 1995 (5 patients), Hib
meningitis occurred evenly, but there were no further pa-
tients after 2004. Although changes were noted within the
study period, no statistically significance was found.Year
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Figure 4. Mortality rates of total followed-up pediatric
bacterial meningitis patients, and recovery and sequela rates
of survivors in different year periods.Complications and outcomes
Fewer than half of the patients (147 patients, 45.5%) had no
complications. The common complications included seizure
(61 patients, 18.9%), hydrocephalus (45 patients, 13.9%),
subdural empyema (40 patients, 12.4%), and hearing
impairment (38 patients, 11.8%). The complication rates in
different age groups and year periods had no significant
fluctuation.
Excluding the 32 patients who were lost to follow-up
(9.9%), 50 patients (17.2% of 291 patients) died. Among the
241 survivors, 160 (66.4%) recovered completely, and 81
(33.6%) had sequelae. There was no significant difference
of the outcome ratio in different age groups. The mortality
rate decreased through the years from 30.8% in 1984e1987
to 12.2% in 2008e2012 (p Z 0.023). Nonetheless, the
sequela rate in survivors increased from 11.1% in
1984e1987 to 41.7% in 2008e2012 (p < 0.001), and the
recovery rate decreased (p Z 0.028; Fig. 4).
Among the four most common pathogens, S. pneumoniae
had the worst outcome (p Z 0.016) and had the highest
mortality rate (26.7%). The other mortality rates were
E. coli (19.0%), and GBS (8.7%). All Hib meningitis patients
survived, but their sequela rate was the highest (41.2%).
The lowest completely recovery rate in survivors (48.5%)
was found in S. pneumonia meningitis patients. Besides the
four most common pathogens, we also compared the out-
comes of other Gram-positive and Gram-negative organisms
as shown in Fig. 5. The outcome in other Gram-positive
organisms was good (p Z 0.046), the overall mortality
rate was 9.5%. Other Gram-negative organisms had a rela-
tively bad outcome (p Z 0.032); the mortality rate was
27.3%.Discussion
In this 29-year-long survey we found several stable condi-
tions and several changing trends of neonatal and childhood
meningitis in our hospital. Numerous factors may
contribute to the changes of the epidemiology, including
birth rates, vaccination administration, prenatal maternal
vaginal bacterial screening, national health insurance, new
antibiotic agents, and novel patient management.
The male-to-female ratio in our patients is higher than
that of the general population. This indicates that males
are prone to have bacterial meningitis. Similar sex
discrepancy in meningitis is found in other countries.13,14
Sex-related differences in reported morbidity for bacte-
rial infections were documented among different age
groups. The reasons may be related to underlying devel-
opment processes, including those affecting the immune,
endocrine, and reproductive systems, or differences in
reporting rates.15
Our hospital has a neonatal intensive care unit caring for
neonates not only born in our hospital but also referred
from other hospitals. The high proportion of neonates in our
study may be partly related to that. A significant trend of
decrement of patient number with increasing age is noted.
In the Japanese nationwide survey, children younger than 1
year accounted for the majority of cases (51.2%), and the
same trend of age relationship was reported.13
Figure 5. Outcomes of pediatric bacterial meningitis of different pathogens.
300 M.-C. Lin et al.Unlike in the USA, where the rate of bacterial meningitis
declined by 55% in the early 1990s,16 our patient number
does not have a such significant decline. The annual
newborn numbers in Taiwan has dropped dramatically in
recent years. The crude birth rate was 19.6/1000 in 1984
and became 8.48/1000 in 2011.17 Taiwan’s national health
insurance started in 1995; before then, some neonates and
children with poor prognosis might be given up due to the
heavy unaffordable medical expense for young parents. We
observed a surge in patient number in that year and a
decreasing slope thereafter. Birth rate and economic sup-
porting system may have great influence for the change of
patient number.
Vaccines are available for some major meningitis path-
ogens, such as Hib, S. pneumoniae, and N. meningitidis.
Single Hib vaccine was introduced to Taiwan prior to 2000
at the parents’ own expense. As a component of self-paid
DTaP-Hib-IPV five-in-one mixed vaccine, Hib vaccine was
remarketed in 2002 and became a government-paid vaccine
in 2010. Hib meningitis was not common prior to vaccina-
tion and disappeared after 2004 in our study. The cost-
effectiveness of Hib vaccine in Taiwan may be not as
good as in some other countries,18,19 but its intangible
benefits could put it into the universal vaccination schedule
as some low-incidence countries.20
In Taiwan, the pneumococcal conjugate vaccine has
been available as a self-paid vaccine since late 2005. High-
risk pneumococcal children were provided with the vaccine
at government expense from July 2009. This vaccine is
expensive and self-payment has been accepted by parents
gradually only in recent years. We did not have pneumo-
coccal meningitis patients in the past 2 years. The cost-
effectiveness of the vaccine has been analyzed and
universal vaccination has been scheduled in Taiwan.21
GBS and E. coli remained the two most common patho-
gens of neonatal meningitis through the study period, but
E. coli overcame GBS and became the most common
pathogen of neonatal meningitis in the past 5-year period.Maternal GBS screening and intra partum antibiotic pro-
phylaxis were implemented in our hospital in 2004 and
became government-paid in 2012. Like early-onset
neonatal sepsis,22 this strategy is effective in decreasing
the incidence of GBS meningitis, but an increase of E. coli
infection is noted.
The burden of meningococcal meningitis is not heavy in
Taiwan: <3% of our patients were infected by meningo-
coccus. The meningococcal vaccine, although its usefulness
has been proven in many countries,23 is not the priority
vaccine for the government budget in Taiwan at present.
Only four Salmonella meningitis patients were recorded in
our patients. Environmental hygiene and public health
improvement may be important factors.24 L. mono-
cytogenes is an important pathogen for neonatal meningitis
in many areas,1,16,25 but not in Asian and some developing
countries.3,4,26 Only two neonates in our study got
L. monocytogenes, presumably related to low availability of
the usual contaminated dietary sources.26
The incidences of complications and prognosis depend on
the era and the duration of follow-up.27 Our complication
incidence was high.27,28 The mortality rate of our patients
was also high,13,28 but improved from almost one-third in the
early period to one-eighth at the end of the study. However,
the sequela rate increased from near one-tenth to two-
fifths. Similar to other reports,27 S. pneumoniae meningitis
has high mortality and morbidity in this study. Although no
Hib meningitis patients died, two-fifths of them had
sequelae. Neonates with GBS meningitis had a better
outcome than those with E. coli meningitis. Excluding the
four common pathogens, meningitis caused by other Gram-
negative bacteria had a worse outcome than other Gram-
positive organisms. Among the other Gram-negative group,
meningitis caused by Pseudomonas aeruginosa, Proteus
mirabilis, E. cloacae, K. pneumoniae, and Salmonella had an
especially high mortality rates (all above 25%).
Due to the diversity and complexity of antibiotic pre-
scription, we could not analyze the impact of new
Bacterial meningitis 301antibiotic agents. We also could not evaluate other novel
management for meningitis. Because these data are from a
single hospital, they are unlikely to represent the exact
epidemiology of the whole area. As there is still no national
pediatric bacterial meningitis surveillance in Taiwan, our
results could reveal the tendency to some extent and offer
information for managing this severe infectious disease.
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